Search results
Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years
Simply Wall St. via Yahoo Finance· 2 days agoBy buying an index fund, investors can approximate the average market return. But if you pick the...
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 3 days agoMerck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 2 days agoMerck has announced that its Phase III KEYNOTE-B21 (ENGOT-en11/GOG-3053) clinical trial of KEYTRUDA...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 3 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through ...
Morningstar· 4 days agoRAHWAY, NJ / ACCESSWIRE / May 8, 2024 / Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, ...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 5 days agoAmong the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NXP...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 4 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 6 days agoMerck (NYSE:MRK) First Quarter 2024 Results Key Financial Results Revenue: US$15.8b (up 8.9% from 1Q...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via AOL· 3 days agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
Merck treatment for a type of uterus cancer fails trial
WSAU Wausau· 3 days ago(Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the main...